Robert J Brychta Selected Research

Robert J Brychta Research Topics

9	Insulin Resistance 12/2021 - 11/2013
8	Obesity 01/2022 - 02/2014
3	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2017
3	Lipodystrophy 12/2021 - 01/2018
2	Body Weight (Weight, Body) 04/2016 - 04/2015
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Type 2 Diabetes Mellitus (MODY) 12/2021
1	Hyperglycemia 01/2020
1	Diabetes Complications 01/2020
1	Overweight 10/2018
1	Hyperphagia (Overeating) 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2011
1	Bradycardia 11/2007

8	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 11/2013
3	Insulin (Novolin)FDA Link 01/2022 - 11/2013
2	Insulin ReceptorIBA 12/2021 - 01/2020
2	LeptinIBA 01/2021 - 01/2018
2	Thyroid HormonesIBA 01/2021 - 01/2020
2	metreleptinIBA 01/2021 - 01/2018
2	serum P-component (CIt)IBA 10/2019 - 11/2014
1	DiglyceridesIBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021
1	HDL CholesterolIBA 01/2020
1	mirabegronIBA 01/2020
1	TabletsIBA 01/2020
1	C-PeptideIBA 10/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	BombesinIBA 04/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2016
1	LipidsIBA 07/2015
1	Oxygen (Dioxygen)IBA 07/2015
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 04/2015
1	setmelanotideIBA 04/2015
1	Adenosine Triphosphate (ATP)IBA 02/2011
1	Yohimbine (Yocon)IBA 11/2007

2	Therapeutics 01/2019 - 02/2014
1	Aftercare (After-Treatment) 01/2018